Top Stories (2026) -
(588 items)
(All links open in new tab)
| Apr 25, 2026 |
Kal Penn Knows Exactly Why People Keep Offering Him Weed Twenty years after Harold & Kumar, the actor talks to High Times about meeting Cheech for the first time, the strain deal he never got and what a Jimmy John’s sandwich campaign says about where cannabis culture actually is right now. |
|---|---|
| Apr 24, 2026 |
Will Trump’s reclassifying of medical marijuana have any impact on criminal justice reform? The Trump administration’s historic move to reclassify state-licensed medical marijuana as a less-dangerous drug was cheered by some advocates but for others, it fell far short for the thousands still incarcerated on federal cannabis-related convictions. The executive order, which acting Attorney General Todd Blanche signed Thursday, does not address current penalties for possessing and selling marijuana or those jailed with yearslong sentences. “While this is a victory, the fight is far from over,” said Jason Ortiz, director of strategic initiatives for the Last Prisoner Project, a nonprofit focused on cannabis criminal justice reform. |
| Apr 24, 2026 |
Youth cannabis use in Canada
What trends are you observing in youth cannabis use since legalization in Canada? One of the most important takeaways is that legalization has not led to a dramatic increase in youth cannabis use. That was a key objective of the Cannabis Act: to protect young people, and nationally, we have not seen the kind of ‘explosion’ in use that some had anticipated. For example, in the Canadian Cannabis Survey 2024, past 12-month cannabis use was 41% among 16-19-year-olds. Since 2018, rates in this age group have fluctuated between 36% and 44%, but they have not steadily increased over time. We see a similar stability story in school-based data. The Canadian Student Alcohol and Drugs Survey (CSADS) 2023–24, which surveys students in Grades 7 to 12, reports 18% past 12-month cannabis use overall – rising from 3% in Grade 7 to 39% in Grade 12. This shows that while cannabis use among youth remains substantial, the overall trend since legalization has been more stable than dramatic, but it still requires attention. With the rise of new products and methods of use, such as vaping, this remains a crucial area to monitor. Prevention and harm reduction efforts should continue to focus on this demographic. |
| Apr 24, 2026 |
Ontario court rejects constitutional challenge on Indigenous cannabis rights In a legal challenge with implications for cannabis retail on Reserve lands in Canada, earlier this year, the Ontario Superior Court of Justice rejected a constitutional challenge filed by four members of the Aamjiwnaang and Chippewas of Kettle and Stony Point First Nations, all located in Ontario. |
| Apr 24, 2026 |
BC cannabis retailer opens consumption patio A cannabis store in Kamloops, BC, opened the city’s first outdoor smoking patio on April 20, 2026. Taste Cannabis, which has operated in Kamloops since 2022, has fenced off the age-gated space next to the store, restricting access to patrons 19 and older. Only cannabis is allowed to be consumed in the space. Taste Cannabis’ Operator Cody Savard told Castanet that he was inspired by another cannabis store in BC’s interior that has an outdoor consumption space, Penticton’s Cannabis Cottage, which opened on April 20, 2024, following provincial rule changes earlier that year. |
| Apr 24, 2026 |
What Happens When Cannabis Magazines are Too Scandalous for Dispensaries? Fat Nugs Magazine’s Kids and Cannabis issue tackled a tough but necessary conversation. A partner dispensary refused to carry it. What does that say about the industry’s willingness to advance the cannabis conversation? |
| Apr 24, 2026 |
Canadian Cannabis Sales Continued to Advance in February Statistics Canada released February retail sales for the country, with cannabis sales decreasing from the January levels, down 7.9% to C$440.5 million from the prior month. The sequential decrease was up 2.0% on a per-day basis more due to the fewer days than in the prior month. January, originally reported at C$466.1 million, was revised higher to C$478.2 million. The sales in February were up 7.9% from a year ago, down from the level last month at 9.4% and in May at 8.3% and 7.5% in June but better than the prior lowest annual growth rate since legalization commenced of -0.9% in September 2024 due to the BC strike. In 2024, total sales increased 4.5% to C$5.39 billion, and they were up 4.1% in 2025 to C$5.62 billion. So far in 2026, sales are up 8.6%. |
| Apr 24, 2026 |
What to Know About Trump’s Reclassification of Medical Marijuana On April 23, acting U.S. attorney general Todd Blanche signed an order changing the federal classification of medical marijuana. The move, which came at the behest of President Donald Trump and will make the substance a Schedule 3 drug, will bring enormous tax benefits to medical marijuana producers in the 40 states where medical use is legal and may speed research into its effects, experts say. But it does not legalize marijuana at the federal level, nor does it change the status of marijuana grown for recreational use. Here’s what you need to know. |
| Apr 24, 2026 |
Reclassifying marijuana as a less dangerous drug might only be the first step for Trump U.S. President Donald Trump’s decision to reclassify state-licensed medical marijuana as a less dangerous drug is a boon for the industry: It gives dispensaries a big tax break, eases some barriers to researching cannabis and could even allow the export of marijuana to other countries. But that might only be Trump’s first step. A new administrative hearing slated for the end of June could result in the reclassification of marijuana more broadly, granting tax and other benefits to state-licensed recreational markets, too. |
| Apr 23, 2026 |
Trump’s Rescheduling Move Could Change the Cannabis Industry Overnight Acting U.S. Attorney General (AG) Todd Blanche signed an order Thursday to reclassify state-licensed medical cannabis as a less dangerous substance. The order shifts the designation of licensed medical cannabis from Schedule I –the most restrictive category of drug classification for substances that have no medical value and potential for abuse including heroin– to the less restrictive Schedule III for substances, or chemicals, defined as drugs with a moderate-to-low potential for physical and psychological dependence alongside Tylenol with Codeine, ketamine, anabolic steroids, and testosterone. |
| Apr 23, 2026 |
Cannabis Use Associated With Lower Likelihood of Metabolic Disorders, Including Hypertension, Type 2 Diabetes, and Obesity Hangzhou, China: Those with a history of cannabis use possess a lower risk of suffering from metabolic disorders – including hypertension, type 2 diabetes, and obesity, according to data published in the journal Nutrition, Metabolism & Cardiovascular Diseases. Chinese researchers assessed the relationship between cannabis use and metabolic syndromes in a nationally representative sample of 91,000 adults. |
| Apr 23, 2026 |
Trump Pushes Congress To Keep Full-Spectrum CBD Legal While Restricting Hemp Products That Pose ‘Health Risks’ President Donald Trump is urging congressional lawmakers to take action to amend a law that threatens to federally recriminalize hemp-derived full-spectrum CBD products in November. |
| Apr 23, 2026 |
Cannabis Stocks Lose Buzz Despite This Landmark Decision Cannabis stocks rose Thursday after the Trump administration, in a landmark decision, reclassified marijuana as a less-dangerous drug. But early stock gains faded. Marijuana now goes from being classified among the most dangerous drugs to Schedule III, a federal designation for drugs with a moderate to low potential for dependence and abuse. |
| Apr 23, 2026 |
Market Outlook: U.S. cannabis reclassification drives stock surge
Marijuana stocks surged after the U.S. Department of Justice reclassified cannabis to a lower-risk category, easing restrictions in a major policy shift. |
| Apr 23, 2026 |
Trump administration eases rules on some marijuana categories. Here's what to know The Trump administration is easing rules on medical marijuana, moving it out of the restrictive Schedule I and into Schedule III — a category shared by drugs such as Tylenol with codeine and anabolic steroids. |
| Apr 23, 2026 |
Marijuana Reclassification Explained: What the Trump Administration’s Schedule 3 Move Actually Means On April 23, 2026, the Trump administration officially moved FDA-approved marijuana products and marijuana products regulated under qualifying state medical marijuana licenses from Schedule I to Schedule III under federal law. If you’re trying to understand what that actually means — for dispensaries, patients, cannabis businesses and federal policy — this is the explainer. |
| Apr 22, 2026 |
‘We’re not going anywhere’: Victoria Cannabis Buyers Club raided Tuesday A day after the annual 4/20 day, the Victoria Police Department raided the Victoria Cannabis Buyers Club, a longstanding unlicensed cannabis club in Victoria. The dispensary is known for selling products with a high level of THC to mostly low-income people with chronic illnesses. “People’s lives are at stake here, we’re not going to give up because of a raid or two or four,” said Ted Smith, founder of VCBC, reiterating, “People’s lives are at stake, I don’t think the provincial government understands that.” |
| Apr 22, 2026 |
Canada’s cannabis export dominance remains despite global price compression, rising standards The global medical cannabis market is growing quickly but inconsistently, with tightening regulatory environments and a competitive supply chain where margins are universally compressing, according to the newest market report from the Global Cannabis Exchange. |
| Apr 22, 2026 |
US set to move to reclassify marijuana as early as Wednesday, Axios reports WASHINGTON, April 22 (Reuters) - The United States administration is expected to move to ?reclassify marijuana as soon as Wednesday, Axios reported, ?citing an official familiar with the matter, sending U.S. stocks of cannabis-related companies higher. The decision to reclassify marijuana would represent one of the ?most significant federal changes to marijuana policy in ?decades, removing barriers to researching the drug's potential ?use cases. |
| Apr 22, 2026 |
Does the UK Media’s Cannabis Coverage Reflect Public Opinion? The Data Says No This morning, the latest in a now-weekly series of stories in the British mainstream press was published in The Times, for the second week in a row taking aim at the advertising practices of some of the UK’s largest clinics. It comes just days after one of the country’s largest and most widely respected polling companies, YouGov, published the results of a representative survey examining the British public’s attitudes towards cannabis. |